本頁面由Tiger Trade Technology Pte. Ltd.提供服務

MBX Biosciences

66.39
+0.06000.09%
盤後66.390.00000.00%19:30 EDT
成交量:53.11萬
成交額:3,522.87萬
市值:31.97億
市盈率:-27.60
高:67.16
開:66.23
低:64.00
收:66.33
52周最高:72.64
52周最低:9.63
股本:4,816.01萬
流通股本:2,762.99萬
量比:1.07
換手率:1.92%
股息:- -
股息率:- -
每股收益(TTM):-2.4052
每股收益(LYR):-2.3824
淨資產收益率:-33.17%
總資產收益率:-22.08%
市淨率:7.81
市盈率(LYR):-27.87

資料載入中...

2026/08/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/08/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/14

重要事件披露

Form 8-K - Current report
2026/07/08

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/08

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/24

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/12

重要事件披露

Form 8-K - Current report
2026/06/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/05

重要事件披露

Form 8-K - Current report
2026/05/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/11

重要事件披露

Form 8-K - Current report
2026/05/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities